Association Between Biomarkers and eGFR Decline in Pulmonary Hypertension - Trial NCT06409624
Access comprehensive clinical trial information for NCT06409624 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Giessen and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Giessen
Timeline & Enrollment
N/A
May 01, 2024
Jul 01, 2026
Primary Outcome
Kidney function decline
Summary
The objective of this study is to examine the association between urinary and plasma
 biomarkers and the change of estimated glomerular filtration rate (eGFR) in patients with
 pulmonary hypertension (PH) as a tool to identify patients at high risk for short-term eGFR
 decline.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06409624
Non-Device Trial